注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Chemomab Therapeutics Ltd(原名:Anchiano Therapeutics Ltd)是一家以色列的生物制药公司。该公司专门从事患者靶向疗法的开发业务,用于治疗多种癌症。其治疗和诊断技术BC-819构成了靶向破坏癌细胞的搜索范式,对癌细胞的周围组织没有影响,也没有观察到的副作用,可以长期、安全地治疗和预防癌症。其患者靶向疗法基于识别仅在肿瘤中表达的特定基因。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Neil Harris Cohen | 58 | 2020 | Independent Director |
Alan Charles Moses | 74 | 2021 | Independent Director |
Arun J. Sanyal | - | - | Member of Scientific Advisory Board |
Nissim Darvish | 59 | 2021 | Independent Chairman |
Massimo Pinzani | - | - | Member of Scientific Advisory Board |
Claude Nicaise | 70 | 2021 | Independent Director |
Adi Mor George | 41 | 2011 | Co-Founder, Chief Scientific Officer, CEO & Executive Director |
Scott L. Friedman | - | - | Member of Scientific Advisory Board |
Jill M. Quigley | 47 | 2022 | Independent Director |
Jacob George | - | - | Member of Scientific Advisory Board |
Dinesh Khanna | - | - | Member of Scientific Advisory Board |
Francesco Del Galdo | - | - | Member of Scientific Advisory Board |
Marco Matucci-Cerinic | - | - | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核